若手研究者セッション
- 第3日 5月17日(水) 10:30~10:45 C会場(会議室1009)
-
3C-O-1030(1P-05) PDF
臨床N-グライコプロテオミクスによる血清膵がんマーカーの探索
Label-free quantitative N-glycoproteomics was performed using serum from patients with advanced pancreatic cancer (PC) and healthy individuals. A total of 6,714 N-glycoforms derived from 501 proteins were identified in patients with advanced PC and healthy individual. We found that mono- or di-sialyl biantennary glycan-modified fibrinogen gamma chain (FGG) was increased in serum from advanced PC group. FGG is expected to be used as a diagnostic marker for PC (Area Under the ROC Curve = 1.0).